trial · primary record
Petosemtamab
Head and Neck Squamous Cell Carcinoma
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 699 |
| Primary completion | 2030-07 |
| Primary endpoint | Overall Survival (OS) |
| Registry ID | NCT06525220 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:43.960Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06525220
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Petosemtamab · compound